Objectives:The purpose of this study was to observe the effect of closed-suction irrigation in patients with brucellosis spondylitis(BS)after one-stage posterior debridement and bone graft fusion with inter-nal fixation.Methods:30 patients with BS after one-stage posterior debridement and bone graft fusion with internal fixation,admitted between August 2022 and December 2023,were randomly divided into control group(15 cases)and observation group(15 cases).In the control group,there were 10 males and 5 females,with an age of 44.1±7.8 years;In the observation group,there were 11 males and 4 females,with an age of 42.1±6.6 years.The control group received conventional treatment after operation,and the observation group received gentamicin closed-suction irrigation treatment on the basis of the control group.From the first day after surgery,gentamicin 80mg+normal saline 3000mL was used to continuously inrigate the wound for 2 weeks.The erythrocyte sedimentation rate(ESR),C-reactive protein(CRP),visual analogue scale(VAS),and Os-westry disability index(ODI)were observed before operaion,and on the 1st day after operation,at 1 week,2 weeks,3 months,6 months,and 1 year after operation.The imaging data of the two groups before operation and at 1 year after operation were compared,including lumbar lordosis(LL)and disc height(DH).At 1 year after operation,the fusion rate was evaluated according to Suk classification.The postoperative complications were recorded.Results:On the first day after operation,the levels of ESR and CRP in both groups were significantly higher than those before operation(P＜0.05).At 1 week after operation,the CRP level of patients in the two groups was significantly lower than that before operation(P＜0.05).At 2 weeks after operation,the ESR of the patients in the observation group was lower than that before operation(P＜0.05),while the ESR in the control group was lower than that before operation at 3 months after operation(P＜0.05).With the passage of time,the VAS score and ODI of the two groups were significantly lower than those before operation(P＜0.05).The ESR,CRP,VAS and ODI in the observation group were significantly lower than those in the control group at 1 week,2 weeks and 3 months after operation(P＜0.05).At 6 months after operation,the ESR and CRP levels of patients in both groups returned to normal.One year after operation,both LL and DH in the two groups of patients increased compared with those before operation(P＜0.05).The overall fusion rate was 100％in the control group and 93.33％in the experimental group(P＞0.05).No postoperative complications occurred during the study in either group.Conclusions:Closed-suction irrigation after one-stage posterior debridement and bone-graft fusion with internal fixation for the patients with BS can help to reduce the inflammatory markers,relieve back pain and improve lumbar function.

Objectives:The purpose of this study was to observe the effect of closed-suction irrigation in patients with brucellosis spondylitis(BS)after one-stage posterior debridement and bone graft fusion with inter-nal fixation.Methods:30 patients with BS after one-stage posterior debridement and bone graft fusion with internal fixation,admitted between August 2022 and December 2023,were randomly divided into control group(15 cases)and observation group(15 cases).In the control group,there were 10 males and 5 females,with an age of 44.1±7.8 years;In the observation group,there were 11 males and 4 females,with an age of 42.1±6.6 years.The control group received conventional treatment after operation,and the observation group received gentamicin closed-suction irrigation treatment on the basis of the control group.From the first day after surgery,gentamicin 80mg+normal saline 3000mL was used to continuously inrigate the wound for 2 weeks.The erythrocyte sedimentation rate(ESR),C-reactive protein(CRP),visual analogue scale(VAS),and Os-westry disability index(ODI)were observed before operaion,and on the 1st day after operation,at 1 week,2 weeks,3 months,6 months,and 1 year after operation.The imaging data of the two groups before operation and at 1 year after operation were compared,including lumbar lordosis(LL)and disc height(DH).At 1 year after operation,the fusion rate was evaluated according to Suk classification.The postoperative complications were recorded.Results:On the first day after operation,the levels of ESR and CRP in both groups were significantly higher than those before operation(P＜0.05).At 1 week after operation,the CRP level of patients in the two groups was significantly lower than that before operation(P＜0.05).At 2 weeks after operation,the ESR of the patients in the observation group was lower than that before operation(P＜0.05),while the ESR in the control group was lower than that before operation at 3 months after operation(P＜0.05).With the passage of time,the VAS score and ODI of the two groups were significantly lower than those before operation(P＜0.05).The ESR,CRP,VAS and ODI in the observation group were significantly lower than those in the control group at 1 week,2 weeks and 3 months after operation(P＜0.05).At 6 months after operation,the ESR and CRP levels of patients in both groups returned to normal.One year after operation,both LL and DH in the two groups of patients increased compared with those before operation(P＜0.05).The overall fusion rate was 100％in the control group and 93.33％in the experimental group(P＞0.05).No postoperative complications occurred during the study in either group.Conclusions:Closed-suction irrigation after one-stage posterior debridement and bone-graft fusion with internal fixation for the patients with BS can help to reduce the inflammatory markers,relieve back pain and improve lumbar function.

AIM: To investigate the effects of agkis-trodon halys venom anti-tumor component (AHVAC-) on the biological behavior of gastric cancer MKN-28 cells. METHODS: Gastric cancer MKN-28 cells were treated with the experimental concentrations (5, 10, 15 μg/mL) of AHAVC- for 24 h. Cell proliferation and toxicity assay (cell counting kit-8, CCK-8) was used to detect the inhibition rates of the cells in different concentrations of AHVAC-. The migration ability of the cells was evaluated by wound-healing and Transwell assay. The apoptosis were observed by laser confocal microscopy with annexin V-mCherry/DAPI double staining, and the apoptosis rates were analyzed by flow cytometry with annexin V-FITC/PI double fluorescence staining. The protein level of Caspease-3 was determined by Western blot. RESULTS: Compared with normal control group, the results of AHVAC- concentration groups showed that with the increase of AHVAC- concentration, the proliferative activity of MN-28 cells decreased gradually (P<0.01), the cell migration ability decreased gradually (P<0.01), and the cell apoptosis rate increased (P<0.05). The expression of apoptosis-related protein Caspease-3 was up-regulated (P<0.01). CONCLUSION: AHVAC- inhibits proliferation and migration of gastric cancer MSN-28 cells and induces apoptosis.

Objective:To investigate the effect of decarbromodiphenyl ether(BDE-209)exposure on the migration ability of triple-negative breast cancer(TNBC)cells and to explore the underlying mechanism.Methods:Human TNBC MDA-MB-231 cells were divided into blank control group and BDE-209 exposure groups(treated with 0.02,0.20,2.00,20.00 and 200.00 ng/mL BDE-209 in high glucose DMEM).Extracellular vehicles(EVs)secreted by MDA-MB-231 cells were isolated by differential ultracentrifugation.Transmission electron microscopy(SEM),nanoparticle tracking analysis(NTA)and Western blotting were performed to characterize the EVs.The effect of the EVs induced by BDE-209 exposure(EVs-BDE-209)on the migration and invasion of MDA-MB-231 cells was detected by wound-healing assay and Transwell test.qRT-PCR was used to measure the miR-221 level in EVs-BDE-209.The expression of MMP9 in MDA-MB-231 cells was determined by Western blotting.Results:Compared with the blank control,BDE-209 exposure increased the tumor cell-derived EVs in dose-dependent manner.The MDA-MB-231 cells co-cultured with EVs released by 200.00 ng/mL BDE-209 exposure showed an 86%increase in cell migration rate,a 1.32-fold higher number of membrane-penetrating cells,a 2.71-fold higher expression level of miR-221,and a 1.62-fold higher expression level of MMP9 compared with the blank control group(all P<0.05).While transfection with anti-miR-221 antibody to decrease miR-221 level in EVs significantly reversed the increased invasion ability of the MDA-MB-231 cells treated with EVs-BDE-209.Conclusion:BDE-209 exposure may promote metastasis potential of MDA-MB-231 cells via EVs-BDE-209 transmitted miR-221.

Objective To investigate the expression of the ubiquitination enzyme UBE2S in different cell types in hepatocellular carcinoma(HCC)microenvironment and its impact on proliferation and stemness of HCC cells.Methods TCGA and CPTAC database were used to analyze the transcriptional and promoter methylation levels and protein expressions of UBE2S in HCC.Specific expression patterns of UBE2S,intercellular communication and key transcription factors in different cell types were analyzed based on single-cell sequencing data from TISCH website.We further examined UBE2S expressions in clinical samples of HCC tissues,HCC cells and T cells using immunohistochemistry and immunofluorescence staining.We also tested the effects of UBE2S knockdown on stemness of HCC-LM3 and HepG2 cells using clone formation experiments and sphere formation assay.Results Analysis based on TCGA database suggested significant overexpression of UBE2S in both paired and non-paired tumor tissues(P<0.001),and its transcriptional level increased with tumor grades.The methylation level of UBE2S promoter was significantly decreased in HCC(P<0.001),and its transcription level increased obviously in HCC with TP53 mutation(P<0.001).Analysis of CPTAC database also demonstrated overexpression of UBE2S protein in HCC tissues(P<0.001).Three prognostic models suggested that HCC patients with high UBE2S expression had poorer prognosis(P<0.001).Single-cell sequencing data analysis revealed high expressions of UBE2S in T cells and high intensities of interaction between endothelial cells,epithelial cells and fibroblasts in HCC microenvironment.Immunohistochemistry and immunofluorescence staining demonstrated high UBE2S expressions in clinical samples of HCC tissues,HCC cells and T cells.In HCC-LM3 and HepG2 cells,UBE2S knockdown significantly inhibited cell clone formation and tumor sphere formation(P<0.05).Conclusion UBE2S is highly expressed in T cells in HCC microenvironment in close correlation with a poor prognosis.High UBE2S expression promotes the stemness of HCC cells.

Objective To investigate the expression of the ubiquitination enzyme UBE2S in different cell types in hepatocellular carcinoma(HCC)microenvironment and its impact on proliferation and stemness of HCC cells.Methods TCGA and CPTAC database were used to analyze the transcriptional and promoter methylation levels and protein expressions of UBE2S in HCC.Specific expression patterns of UBE2S,intercellular communication and key transcription factors in different cell types were analyzed based on single-cell sequencing data from TISCH website.We further examined UBE2S expressions in clinical samples of HCC tissues,HCC cells and T cells using immunohistochemistry and immunofluorescence staining.We also tested the effects of UBE2S knockdown on stemness of HCC-LM3 and HepG2 cells using clone formation experiments and sphere formation assay.Results Analysis based on TCGA database suggested significant overexpression of UBE2S in both paired and non-paired tumor tissues(P<0.001),and its transcriptional level increased with tumor grades.The methylation level of UBE2S promoter was significantly decreased in HCC(P<0.001),and its transcription level increased obviously in HCC with TP53 mutation(P<0.001).Analysis of CPTAC database also demonstrated overexpression of UBE2S protein in HCC tissues(P<0.001).Three prognostic models suggested that HCC patients with high UBE2S expression had poorer prognosis(P<0.001).Single-cell sequencing data analysis revealed high expressions of UBE2S in T cells and high intensities of interaction between endothelial cells,epithelial cells and fibroblasts in HCC microenvironment.Immunohistochemistry and immunofluorescence staining demonstrated high UBE2S expressions in clinical samples of HCC tissues,HCC cells and T cells.In HCC-LM3 and HepG2 cells,UBE2S knockdown significantly inhibited cell clone formation and tumor sphere formation(P<0.05).Conclusion UBE2S is highly expressed in T cells in HCC microenvironment in close correlation with a poor prognosis.High UBE2S expression promotes the stemness of HCC cells.

Purpose To investigate the clinicopathological features of primary mucoepidermoid carcinoma of the liver(PMCL).Methods The history,clinical data,pathological diagnosis,differential diagnosis,treatment and prognosis of 4 patients with PMCL were retrospectively analyzed.Results All four tumors were located in the left half of the liver and were sol-itary.Microscopic examination showed that tumor cells were composed of three types of cells:epidermal like cells,interme-diate cells,and mucinous cells,with varying proportions.Im-munophenotype:tumor cells showed diffuse strong positivity for CA199 and CK19,while mucous cells showed focal positivity for CEA.CK7 mainly expressed in epidermal like cells and mucous cells,while CK5/6,p40,and p63 expressed in epidermal like cells and intermediate cells.Special staining with AB,PAS,and mucin carmine confirmed the presence of mucous cells,Ki67 proliferation index ranged from 30％to 40％.FISH testing:no MAML2 gene breakage or rearrangement was detected in 4 cases of PMCL,and MAML2 gene amplification occurred in 1 case of tumor.Conclusion The incidence of PMCL is low and present with non-specific clinical manifestations,which often leads to misdiagnosis.The diagnosis should be differentiated from bile duct adenocarcinoma and adenosquamous carcinoma.Moreover,there is currently no established standard treatment for PMCL and has a poor prognosis.

Purpose To investigate the clinicopathological features of primary mucoepidermoid carcinoma of the liver(PMCL).Methods The history,clinical data,pathological diagnosis,differential diagnosis,treatment and prognosis of 4 patients with PMCL were retrospectively analyzed.Results All four tumors were located in the left half of the liver and were sol-itary.Microscopic examination showed that tumor cells were composed of three types of cells:epidermal like cells,interme-diate cells,and mucinous cells,with varying proportions.Im-munophenotype:tumor cells showed diffuse strong positivity for CA199 and CK19,while mucous cells showed focal positivity for CEA.CK7 mainly expressed in epidermal like cells and mucous cells,while CK5/6,p40,and p63 expressed in epidermal like cells and intermediate cells.Special staining with AB,PAS,and mucin carmine confirmed the presence of mucous cells,Ki67 proliferation index ranged from 30％to 40％.FISH testing:no MAML2 gene breakage or rearrangement was detected in 4 cases of PMCL,and MAML2 gene amplification occurred in 1 case of tumor.Conclusion The incidence of PMCL is low and present with non-specific clinical manifestations,which often leads to misdiagnosis.The diagnosis should be differentiated from bile duct adenocarcinoma and adenosquamous carcinoma.Moreover,there is currently no established standard treatment for PMCL and has a poor prognosis.

Objective:To evaluate the clinical effect of microbotox injection of botulinum toxin type A in improving the fine lines of lower eyelid skin and achieving the rejuvenation of the eye area.Methods:The clinical data of patients with mildly sagging lower eyelid skin and fine wrinkles admitted to Facial and Neck Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Deparment of Plastic and Cosmetic Surgery, Guangyuan Central Hospital; Department of Dermatology, People’s Hospital of Qingshen County; Department of Plastic and Cosmetic Surgery, Dujiangyan People’s Hospital; Devision of Women’s Healthcare, Panzhihua Maternal and Child Hospital; Chengdu Badachu Cosmetic Hospital from August 2022 to January 2023 were analyzed retrospectively. Using the microbotox injection method, the botulinum toxin type A with a diluted concentration of 8 U/ml was micro-injected into the dermis layer or between the dermis and the superficial muscle layer at an interval of 0.6 cm, and a single point injection of 0.2 U. The injection range was the anatomical distribution range of the orbicularis oculi muscle. After treatment, patients were followed up to investigate patient satisfaction, which was divided into very satisfied, satisfied, dissatisfied and very dissatisfied, and to calculate subjective satisfaction (percentage of the number of very satisfied and satisfied cases in the total number of cases). At the same time, a independent physician used the global aesthetic improvement scale (GAIS) to evaluate the effect based on the patient’s photos before treatment and during follow-up. 5 indicates as worse than before, 4 as no improvement, 3 as were slight improvement, 2 as moderate improvement, and 1 as significant improvement. SPSS 24.0 software was used for descriptive analysis of the data.Results:A total of 23 patients were enrolled, including 1 male and 22 females, aged (36.4±2.5) years old. The follow-up was 1-6 months, with an average of 1.4 months, and the subjective satisfaction of patients was 100% (23/23). The result of the independent physician evaluation were as follows: the overall cosmetic improvement score of the observers was 1.26±0.54, 100% (23/23) of the patients reached the standard of obvious or moderate improvement. In terms of complications, 2 patients presented local epidermis bruises after injection, who recovered within 1 week; 1 patient complained of pain after injection, which was significantly relieved 12 hours later. No ectropion, symblepharon, facial palsy, dry eyes, or other complications were observed.Conclusion:Application of botulinum toxin type A microbotox injection can improve periorbital wrinkles and improve skin texture at the same time, and the therapeutic effect is definite.

Objective:To evaluate the clinical effect of microbotox injection of botulinum toxin type A in improving the fine lines of lower eyelid skin and achieving the rejuvenation of the eye area.Methods:The clinical data of patients with mildly sagging lower eyelid skin and fine wrinkles admitted to Facial and Neck Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Deparment of Plastic and Cosmetic Surgery, Guangyuan Central Hospital; Department of Dermatology, People’s Hospital of Qingshen County; Department of Plastic and Cosmetic Surgery, Dujiangyan People’s Hospital; Devision of Women’s Healthcare, Panzhihua Maternal and Child Hospital; Chengdu Badachu Cosmetic Hospital from August 2022 to January 2023 were analyzed retrospectively. Using the microbotox injection method, the botulinum toxin type A with a diluted concentration of 8 U/ml was micro-injected into the dermis layer or between the dermis and the superficial muscle layer at an interval of 0.6 cm, and a single point injection of 0.2 U. The injection range was the anatomical distribution range of the orbicularis oculi muscle. After treatment, patients were followed up to investigate patient satisfaction, which was divided into very satisfied, satisfied, dissatisfied and very dissatisfied, and to calculate subjective satisfaction (percentage of the number of very satisfied and satisfied cases in the total number of cases). At the same time, a independent physician used the global aesthetic improvement scale (GAIS) to evaluate the effect based on the patient’s photos before treatment and during follow-up. 5 indicates as worse than before, 4 as no improvement, 3 as were slight improvement, 2 as moderate improvement, and 1 as significant improvement. SPSS 24.0 software was used for descriptive analysis of the data.Results:A total of 23 patients were enrolled, including 1 male and 22 females, aged (36.4±2.5) years old. The follow-up was 1-6 months, with an average of 1.4 months, and the subjective satisfaction of patients was 100% (23/23). The result of the independent physician evaluation were as follows: the overall cosmetic improvement score of the observers was 1.26±0.54, 100% (23/23) of the patients reached the standard of obvious or moderate improvement. In terms of complications, 2 patients presented local epidermis bruises after injection, who recovered within 1 week; 1 patient complained of pain after injection, which was significantly relieved 12 hours later. No ectropion, symblepharon, facial palsy, dry eyes, or other complications were observed.Conclusion:Application of botulinum toxin type A microbotox injection can improve periorbital wrinkles and improve skin texture at the same time, and the therapeutic effect is definite.